Terminal differentiation is not a major determinant for the success of stem cell therapy - Cross-talk between muscle-derived stem cells and host cells

Stem Cell Research and Therapy

Volumn 2, Issue 4, 2011, Pages

  Gharaibeh, Burhan ^a,b   Lavasani, Mitra ^a   Cummins, James H ^a   Huard, Johnny ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICULAR CARTILAGE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL FATE; HEART INJURY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR INTERACTION; MUSCLE DERIVED STEM CELL; NONHUMAN; OSTEOARTHRITIS; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; BIOLOGICAL THERAPY; CHONDROPATHY; CYTOLOGY; HEART DISEASE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; TUMOR MICROENVIRONMENT;

ANIMALS; CARTILAGE DISEASES; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; HEART DISEASES; HUMANS; MICE; MUSCLE FIBERS, SKELETAL; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY;

EID: 80052440275     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt72     Document Type: Review

References (132)

1. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Gharaibeh B, Lu A, Tebbets J, Zheng B, Feduska J, Crisan M, Péault B, Cummins J, Huard J, Nat Protoc 2008 3 1501 1509 10.1038/nprot.2008.142 18772878
2. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J, J Cell Biol 2002 157 851 864 10.1083/jcb.200108150 12021255 (Pubitemid 34847822)
3. Muscle-derived stem cells: a model for stem cell therapy in regenerative medicine. Gharaibeh B, Drowley L, Huard J, Stem Cells and Regenerative Medicine New York: Humana Press, Appasani K, Appasani RK, 2011 565 578
4. Muscle-derived stem cells for tissue engineering and regenerative therapy. Usas A, Huard J, Biomaterials 2007 28 5401 5406 10.1016/j.biomaterials. 2007.09.008 17915311 (Pubitemid 47599647)
5. Regenerative medicine based on muscle-derived stem cells. Huard J, Gharaibeh B, Usas A, Operative Techniques Orthopaedics 2010 20 119 126 10.1053/j.oto.2009.10.013
6. Cell therapy for cardiovascular disease: what cells, what diseases and for whom? Caplice NM, Gersh BJ, Alegria JR, Nat Clin Pract Cardiovasc Med 2005 2 37 43 10.1038/ncpcardio0073 16265341 (Pubitemid 40823208)
7. Regenerating the heart. Laflamme MA, Murry CE, Nat Biotechnol 2005 23 845 856 10.1038/nbt1117 16003373 (Pubitemid 43093128)
8. Review article: current status of myocardial regeneration: new cell sources and new strategies. Rangappa S, Makkar R, Forrester J, J Cardiovasc Pharmacol Ther 2010 15 338 343 10.1177/1074248410376382 21098418
9. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. Etzion S, Battler A, Barbash IM, Cagnano E, Zarin P, Granot Y, Kedes LH, Kloner RA, Leor J, J Mol Cell Cardiol 2001 33 1321 1330 10.1006/jmcc.2000.1391 11437538 (Pubitemid 32613424)
10. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA, Circulation 1996 94 9 Suppl I332 336 8901770
11. Cardiomyocyte transplantation improves heart function. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, Rao V, Ivanov J, Ann Thorac Surg 1996 62 654 660 discussion 660-661 10.1016/S0003-4975(96)00389-X 8783989 (Pubitemid 26301755)
12. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Reinecke H, Zhang M, Bartosek T, Murry CE, Circulation 1999 100 193 202 10402450 (Pubitemid 29330019)
13. Cardiomyocyte transplantation in a porcine myocardial infarction model. Watanabe E, Smith DM Jr, Delcarpio JB, Sun J, Smart FW, Van Meter CH Jr, Claycomb WC, Cell Transplant 1998 7 239 246 10.1016/S0963-6897(98)00011-6 9647433 (Pubitemid 28280852)
14. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA, J Mol Cell Cardiol 1999 31 513 522 10.1006/jmcc.1998.0882 10198183 (Pubitemid 29121638)
15. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Koh GY, Soonpaa MH, Klug MG, Field LJ, Am J Physiol 1993 264 1727 1733 8498586
16. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. Van Meter CH Jr, Claycomb WC, Delcarpio JB, Smith DM, deGruiter H, Smart F, Ochsner JL, J Thorac Cardiovasc Surg 1995 110 1442 1448 10.1016/S0022-5223(95)70067-6 7475196
17. Autologous heart cell transplantation improves cardiac function after myocardial injury. Sakai T, Li RK, Weisel RD, Mickle DA, Kim EJ, Tomita S, Jia ZQ, Yau TM, Ann Thorac Surg 1999 68 2074 2080 discussion 2080-2081 10.1016/S0003-4975(99)01148-0 10616980 (Pubitemid 30028074)
18. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA, Cell Transplant 2000 9 359 368 10972335 (Pubitemid 30655687)
19. Construction of a bioengineered cardiac graft. Li RK, Yau TM, Weisel RD, Mickle DA, Sakai T, Choi A, Jia ZQ, J Thorac Cardiovasc Surg 2000 119 368 375 10.1016/S0022-5223(00)70193-0 10649213 (Pubitemid 30091810)
20. Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. Tamaki T, Akatsuka A, Okada Y, Uchiyama Y, Tono K, Wada M, Hoshi A, Iwaguro H, Iwasaki H, Oyamada A, Asahara T, PLoS ONE 2008 3 1789 10.1371/journal.pone.0001789 18335059 (Pubitemid 351917326)
21. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Kessler PD, Byrne BJ, Annu Rev Physiol 1999 61 219 242 10.1146/annurev.physiol.61.1.219 10099688 (Pubitemid 29143170)
22. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE, Nat Med 1998 4 929 933 10.1038/nm0898-929 9701245 (Pubitemid 28364032)
23. Cardiac assistance from skeletal muscle: a reappraisal. Salmons S, Eur J Cardiothorac Surg 2009 35 204 213 10.1016/j.ejcts.2008.09.015 18954996
24. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. Klug MG, Soonpaa MH, Koh GY, Field LJ, J Clin Invest 1996 98 216 224 10.1172/JCI118769 8690796 (Pubitemid 26243839)
25. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF, J Appl Physiol 2002 92 288 296 10.1063/1.1481962 11744672 (Pubitemid 34783313)
26. Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Paul D, Samuel SM, Maulik N, Antioxid Redox Signal 2009 11 1841 1855 10.1089/ars.2009.2455 19260767
27. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC, J Thorac Cardiovasc Surg 2001 122 699 705 10.1067/mtc.2001.116317 11581601
28. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508 (Pubitemid 40562318)
29. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Hirschi KK, Goodell MA, Gene Ther 2002 9 648 652 10.1038/sj.gt.3301722 12032711 (Pubitemid 34567494)
30. Bone marrow cells regenerate infarcted myocardium. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Nature 2001 410 701 705 10.1038/35070587 11287958 (Pubitemid 32290358)
31. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Proc Natl Acad Sci USA 2001 98 10344 10349 10.1073/pnas.181177898 11504914 (Pubitemid 32803022)
32. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S, Nat Med 2001 7 430 436 10.1038/86498 11283669 (Pubitemid 32298545)
33. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
34. Evidence for circulating bone marrow-derived endothelial cells. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP, Blood 1998 92 362 367 9657732 (Pubitemid 28323695)
35. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T, Nat Med 1999 5 434 438 10.1038/7434 10202935 (Pubitemid 29180584)
36. Adult cardiac stem cells are multipotent and support myocardial regeneration. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P, Cell 2003 114 763 776 10.1016/S0092-8674(03)00687-1 14505575 (Pubitemid 37186770)
37. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ, Dev Biol 2004 265 262 275 10.1016/j.ydbio.2003.09.028 14697368 (Pubitemid 38018836)
38. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD, Proc Natl Acad Sci USA 2003 100 12313 12318 10.1073/pnas. 2132126100 14530411 (Pubitemid 37271557)
39. A myocardial lineage derives from Tbx18 epicardial cells. Cai CL, Martin JC, Sun Y, Cui L, Wang L, Ouyang K, Yang L, Bu L, Liang X, Zhang X, Stallcup WB, Denton CP, McCulloch A, Chen J, Evans SM, Nature 2008 454 104 108 10.1038/nature06969 18480752 (Pubitemid 351931969)
40. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J, Jiang D, von Gise A, Ikeda S, Chien KR, Pu WT, Nature 2008 454 109 113 10.1038/nature07060 18568026 (Pubitemid 351931979)
41. Stem-cell therapy for cardiac disease. Segers VF, Lee RT, Nature 2008 451 937 942 10.1038/nature06800 18288183 (Pubitemid 351301749)
42. Cardiac cell repair therapy: a clinical perspective. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A, Mayo Clin Proc 2009 84 876 892 10.4065/84.10.876 19797777
43. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Wang F, Guan J, Adv Drug Deliv Rev 2010 62 784 797 10.1016/j.addr.2010. 03.001 20214939
44. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW, J Am Coll Cardiol 2007 50 1761 1767 10.1016/j.jacc.2007.07.041 17964040 (Pubitemid 47600592)
45. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E, Circulation 2005 112 1748 1755 10.1161/CIRCULATIONAHA.105.547810 16172284 (Pubitemid 41368151)
46. Myoblast transplantation for heart failure. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP, Lancet 2001 357 279 280 10.1016/S0140-6736(00)03617-5 11214133 (Pubitemid 32120862)
47. Cell transplantation for myocardial repair: an experimental approach. Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC, Cell Transplant 1992 1 383 390 1344311
48. Skeletal muscle stem cells do not trans-differentiate into cardiomyocytes after cardiac grafting. Reinecke H, Poppa V, Murry CE, J Mol Cell Cardiol 2002 34 241 249 10.1006/jmcc.2001.1507 11851363 (Pubitemid 35222833)
49. Development of a novel method for cell transplantation through the coronary artery. Suzuki K, Brand NJ, Smolenski RT, Jayakumar J, Murtuza B, Yacoub MH, Circulation 2000 102 19 Suppl 3 II359 364 11082414
50. Cellular transplantation: hurdles remaining before widespread clinical use. Menasche P, Curr Opin Cardiol 2004 19 154 161 10.1097/00001573-200403000- 00016 15075744 (Pubitemid 38373131)
51. Rapid death of injected myoblasts in myoblast transfer therapy. Fan Y, Maley M, Beilharz M, Grounds M, Muscle Nerve 1996 19 853 860 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8 8965839 (Pubitemid 26190645)
52. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA, J Cell Biol 1999 144 1113 1122 10.1083/jcb.144.6.1113 10087257 (Pubitemid 29157292)
53. Gene transfer into skeletal muscles by isogenic myoblasts. Huard J, Acsadi G, Jani A, Massie B, Karpati G, Hum Gene Ther 1994 5 949 958 10.1089/hum.1994.5.8-949 7948144 (Pubitemid 24304756)
54. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH, Huard J, Mol Ther 2005 12 1130 1141 10.1016/j.ymthe.2005.07.686 16125468 (Pubitemid 41723047)
55. The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine. Sakai T, Ling Y, Payne TR, Huard J, Trends Cardiovasc Med 2002 12 115 120 10.1016/S1050-1738(01)00161-X 12007736 (Pubitemid 34462181)
56. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Payne TR, Oshima H, Sakai T, Ling Y, Gharaibeh B, Cummins J, Huard J, Gene Ther 2005 12 1264 1274 10.1038/sj.gt.3302521 15843810 (Pubitemid 41195117)
57. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H, Huard J, J Am Coll Cardiol 2007 50 1677 1684 10.1016/j.jacc.2007.04.100 17950150 (Pubitemid 47562673)
58. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Deasy BM, Feduska JM, Payne TR, Li Y, Ambrosio F, Huard J, Mol Ther 2009 17 1788 1798 10.1038/mt.2009.136 19603004
59. The vascular wall as a source of stem cells. Tavian M, Zheng B, Oberlin E, Crisan M, Sun B, Huard J, Peault B, Ann N Y Acad Sci 2005 1044 41 50 10.1196/annals.1349.006 15958696 (Pubitemid 40967593)
60. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Crisan M, Deasy B, Gavina M, Zheng B, Huard J, Lazzari L, Péault B, Methods Cell Biol 2008 86 295 309 18442653
61. Prospective identification of myogenic endothelial cells in human skeletal muscle. Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, Cassino T, Gharaibeh B, Deasy BM, Huard J, Péault B, Nat Biotechnol 2007 25 1025 1034 10.1038/nbt1334 17767154 (Pubitemid 47517642)
62. A perivascular origin for mesenchymal stem cells in multiple human organs. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B, Cell Stem Cell 2008 3 301 313 10.1016/j.stem.2008.07.003 18786417
63. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. Okada M, Payne TR, Zheng B, Oshima H, Momoi N, Tobita K, Keller BB, Phillippi JA, Péault B, Huard J, J Am Coll Cardiol 2008 52 1869 1880 10.1016/j.jacc.2008.07.064 19038685
64. The anti-fibrotic and anti-inflammatory potentials of purified human muscle-derived perivascular cells for the treatment of myocardial infarction. Chen CW, Corselli M, Okada M, Crisan M, Tobita K, Péault B, Huard J, Circulation 2010 122 20465
65. Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction. Ciulla MM, Montelatici E, Ferrero S, Braidotti P, Paliotti R, Annoni G, De Camilli E, Busca G, Chiappa L, Rebulla P, Magrini F, Lazzari L, J Transl Med 2008 6 30 10.1186/1479-5876-6-30 18549470 (Pubitemid 351917275)
66. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE, Circulation 2004 109 1543 1549 10.1161/01.CIR.0000124062.31102.57 15023891 (Pubitemid 38420184)
67. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. Chen L, Tredget EE, Wu PY, Wu Y, PLoS One 2008 3 1886 10.1371/journal.pone.0001886 18382669 (Pubitemid 351943822)
68. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI, Ann Thorac Surg 2005 80 229 236 10.1016/j.athoracsur.2005.02.072 15975372 (Pubitemid 40840214)
69. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Qian H, Yang H, Xu W, Yan Y, Chen Q, Zhu W, Cao H, Yin Q, Zhou H, Mao F, Chen Y, Int J Mol Med 2008 22 325 332 18698491
70. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC, Nature 2004 428 668 673 10.1038/nature02460 15034594 (Pubitemid 38524811)
71. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Wang L, Deng J, Tian W, Xiang B, Yang T, Li G, Wang J, Gruwel M, Kashour T, Rendell J, Glogowski M, Tomanek B, Freed D, Deslauriers R, Arora RC, Tian G, Am J Physiol Heart Circ Physiol 2009 297 1020 1031 10.1152/ajpheart.01082.2008 19574490
72. Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Santhanam AV, Smith LA, He T, Nath KA, Katusic ZS, Circ Res 2007 100 1379 1388 10.1161/01.RES. 0000265848.55035.5d 17395873 (Pubitemid 46742928)
73. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS, Circulation 2005 112 1618 1627 10.1161/CIRCULATIONAHA.104.503433 16145003 (Pubitemid 41324524)
74. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, Plotkin M, Goligorsky MS, Kidney Int 2008 74 879 889 10.1038/ki.2008.304 18596729
75. Regeneration gaps: observations on stem cells and cardiac repair. Murry CE, Reinecke H, Pabon LM, J Am Coll Cardiol 2006 47 1777 1785 10.1016/j.jacc.2006.02.002 16682301
76. Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Matsumoto T, Kuroda R, Mifune Y, Kawamoto A, Shoji T, Miwa M, Asahara T, Kurosaka M, Bone 2008 43 434 439 10.1016/j.bone.2008.05.001 18547890
77. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. Matsumoto T, Mifune Y, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Suzuki T, Oyamada A, Horii M, Yokoyama A, Nishimura H, Lee SY, Miwa M, Doita M, Kurosaka M, Asahara T, J Cell Physiol 2008 215 234 242 10.1002/jcp.21309 18205179 (Pubitemid 351363208)
78. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Matsumoto T, Kawamoto A, Kuroda R, Ishikawa M, Mifune Y, Iwasaki H, Miwa M, Horii M, Hayashi S, Oyamada A, Nishimura H, Murasawa S, Doita M, Kurosaka M, Asahara T, Am J Pathol 2006 169 1440 1457 10.2353/ajpath.2006.060064 17003498 (Pubitemid 351194376)
79. Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Urish KL, Vella JB, Okada M, Deasy BM, Tobita K, Keller BB, Cao B, Piganelli JD, Huard J, Mol Biol Cell 2009 20 509 520 10.1091/mbc.E08-03-0274 19005220
80. Cellular antioxidant levels influence muscle stem cell therapy. Drowley L, Okada M, Beckman S, Vella J, Keller B, Tobita K, Huard J, Mol Ther 2010 18 1865 1873 10.1038/mt.2010.160 20664528
81. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L, J Thorac Cardiovasc Surg 2008 135 799 808 10.1016/j.jtcvs.2007.07.071 18374759 (Pubitemid 351417929)
82. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M, Cardiovasc Res 2008 77 134 142 18006467 (Pubitemid 351195153)
83. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li RK, Steinhoff G, Stem Cells 2007 25 2118 2127 10.1634/stemcells.2006-0771 17478584 (Pubitemid 47258191)
84. Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb. Yin M, Pacifici M, Dev Dyn 2001 222 522 533 10.1002/dvdy.1212 11747085 (Pubitemid 33042149)
85. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. Maes C, Stockmans I, Moermans K, Van Looveren R, Smets N, Carmeliet P, Bouillon R, Carmeliet G, J Clin Invest 2004 113 188 199 14722611 (Pubitemid 38544204)
86. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N, Nat Med 1999 5 623 628 10.1038/9467 10371499 (Pubitemid 29289424)
87. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F, J Cell Sci 2000 113 59 69 10591625 (Pubitemid 30066333)
88. Development and regulation of osteophyte formation during experimental osteoarthritis. Hashimoto S, Creighton-Achermann L, Takahashi K, Amiel D, Coutts RD, Lotz M, Osteoarthritis Cartilage 2002 10 180 187 10.1053/joca.2001.0505 11869078 (Pubitemid 34189567)
89. Angiogenesis in osteoarthritis. Ashraf S, Walsh DA, Curr Opin Rheumatol 2008 20 573 580 10.1097/BOR.0b013e3283103d12 18698180
90. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B, Mentlein R, J Pathol 2004 202 367 374 10.1002/path.1527 14991903 (Pubitemid 38325247)
91. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Pufe T, Petersen W, Tillmann B, Mentlein R, Arthritis Rheum 2001 44 1082 1088 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X 11352239 (Pubitemid 32433613)
92. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Pfander D, Körtje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B, Ann Rheum Dis 2001 60 1070 1073 10.1136/ard.60.11.1070 11602483 (Pubitemid 32989184)
93. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, Matsumoto H, Toyama Y, Okada Y, Am J Pathol 2003 162 171 181 10.1016/S0002-9440(10)63808-4 12507900 (Pubitemid 36041999)
94. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L, N Engl J Med 1994 331 889 895 10.1056/ NEJM199410063311401 8078550 (Pubitemid 24299869)
95. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. Ochi M, Uchio Y, Kawasaki K, Wakitani S, Iwasa J, J Bone Joint Surg Br 2002 84 571 578 10.1302/0301-620X. 84B4.11947 12043781 (Pubitemid 34578510)
96. Treatment of deep cartilage defects of the knee using autologous chondrograft transplantation and by abrasive techniques - a randomized controlled study. Visna P, Pasa L, Cizmar I, Hart R, Hoch J, Acta Chir Belg 2004 104 709 714 15663280 (Pubitemid 40115687)
97. The healing and regeneration of articular cartilage. O'Driscoll SW, J Bone Joint Surg Am 1998 80 1795 1812 9875939 (Pubitemid 29013814)
98. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. Bentley G, Biant LC, Carrington RW, Akmal M, Goldberg A, Williams AM, Skinner JA, Pringle J, J Bone Joint Surg Br 2003 85 223 230 10.1302/0301-620X.85B2.13543 12678357 (Pubitemid 36410545)
99. New horizons in the treatment of osteoarthritis of the knee. LaPrade RF, Swiontkowski MF, JAMA 1999 281 876 878 10.1001/jama.281.10.876 10078464 (Pubitemid 29124623)
100. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S, Cell Transplant 2004 13 595 600 10.3727/000000004783983747 15565871 (Pubitemid 39557438)
101. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M, Osteoarthritis Cartilage 2007 15 226 231 10.1016/j.joca.2006.08.008 17002893 (Pubitemid 46132105)
102. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Kuroda R, Usas A, Kubo S, Corsi K, Peng H, Rose T, Cummins J, Fu FH, Huard J, Arthritis Rheum 2006 54 433 442 10.1002/art.21632 16447218 (Pubitemid 43228617)
103. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Hashimoto S, Ochs RL, Komiya S, Lotz M, Arthritis Rheum 1998 41 1632 1638 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A 9751096 (Pubitemid 28459922)
104. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Pufe T, Lemke A, Kurz B, Petersen W, Tillmann B, Grodzinsky AJ, Mentlein R, Am J Pathol 2004 164 185 192 10.1016/S0002-9440(10)63109-4 14695332 (Pubitemid 38364603)
105. Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Tanaka E, Aoyama J, Miyauchi M, Takata T, Hanaoka K, Iwabe T, Tanne K, Histochem Cell Biol 2005 123 275 281 10.1007/s00418-005-0773-6 15856277 (Pubitemid 40674678)
106. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Afuwape AO, Kiriakidis S, Paleolog EM, Histol Histopathol 2002 17 961 972 12168808 (Pubitemid 34784680)
107. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. Matsumoto Y, Tanaka K, Hirata G, Hanada M, Matsuda S, Shuto T, Iwamoto Y, J Immunol 2002 168 5824 5831 12023386 (Pubitemid 34556170)
108. Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/ macrophages. Murakami M, Iwai S, Hiratsuka S, Yamauchi M, Nakamura K, Iwakura Y, Shibuya M, Blood 2006 108 1849 1856 10.1182/blood-2006-04-016030 16709927 (Pubitemid 44394993)
109. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Afuwape AO, Feldmann M, Paleolog EM, Gene Ther 2003 10 1950 1960 10.1038/sj.gt.3302104 14528319 (Pubitemid 37337071)
110. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. De Bandt M, Ben Mahdi MH, Ollivier V, Grossin M, Dupuis M, Gaudry M, Bohlen P, Lipson KE, Rice A, Wu Y, Gougerot-Pocidalo MA, Pasquier C, J Immunol 2003 171 4853 4859 14568965 (Pubitemid 37310607)
111. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Matsumoto T, Cooper GM, Gharaibeh B, Meszaros LB, Li G, Usas A, Fu FH, Huard J, Arthritis Rheum 2009 60 1390 1405 10.1002/art.24443 19404941
112. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Kubo S, Cooper GM, Matsumoto T, Phillippi JA, Corsi KA, Usas A, Li G, Fu FH, Huard J, Arthritis Rheum 2009 60 155 165 10.1002/art.24153 19116905
113. Myoblast-mediated gene transfer to the joint. Day CS, Kasemkijwattana C, Menetrey J, Floyd SS Jr, Booth D, Moreland MS, Fu FH, Huard J, J Orthop Res 1997 15 894 903 10.1002/jor.1100150616 9497816 (Pubitemid 28121504)
114. Paracrine effect of transplanted rib chondrocyte spheroids supports formation of secondary cartilage repair tissue. Gelse K, Brem M, Klinger P, Hess A, Swoboda B, Hennig F, Olk A, J Orthop Res 2009 27 1216 1225 10.1002/jor.20874 19274742
115. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. Peng H, Usas A, Gearhart B, Olshanski A, Shen HC, Huard J, J Bone Miner Res 2004 19 630 641 10.1359/JBMR.040102 15005851 (Pubitemid 41071224)
116. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. Shen HC, Peng H, Usas A, Gearhart B, Fu FH, Huard J, J Gene Med 2004 6 984 991 10.1002/jgm.588 15352071 (Pubitemid 40228113)
117. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Peng H, Usas A, Gearhart B, Young B, Olshanski A, Huard J, Mol Ther 2004 9 885 894 10.1016/j.ymthe.2004.02.023 15194055 (Pubitemid 38878134)
118. Transplanted chondrocytes inhibit endochondral ossification within cartilage repair tissue. Blanke M, Carl HD, Klinger P, Swoboda B, Hennig F, Gelse K, Calcif Tissue Int 2009 85 421 433 10.1007/s00223-009-9288-9 19763370
119. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA, Nature 2005 433 760 764 10.1038/nature03260 15716955 (Pubitemid 40292986)
120. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, Pollett JB, Sun B, Urish KL, Gharaibeh BM, Cao B, Rubin RT, Huard J, J Cell Biol 2007 177 73 86 10.1083/jcb.200612094 17420291 (Pubitemid 46588403)
121. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. Corsi KA, Pollett JB, Phillippi JA, Usas A, Li G, Huard
122. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos M, Hagège AA, Aranda P, Andreu EJ, Menasché P, Prásper F, Eur J Heart Fail 2008 10 1065 1072 10.1016/j.ejheart.2008.08.002 18805052
123. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Léobon B, Robidel E, Borsani P, Le Lorc'h M, Bissery A, Chomienne C, Bruneval P, Marolleau JP, Vilquin JT, Hagège A, Samuel JL, Menasché P, J Am Coll Cardiol 2004 44 458 463 10.1016/j.jacc.2004.03.083 15261948 (Pubitemid 38950611)
124. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS, Stroke 2004 35 2378 2384 10.1161/01.STR.0000141893.33677.5d 15345801 (Pubitemid 39311267)
125. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C, Am J Physiol Renal Physiol 2007 292 1626 1635 10.1152/ajprenal.00339.2006 17213465 (Pubitemid 46701891)
126. Cartilage regeneration by bone marrow cells-seeded scaffolds. Wegener B, Schrimpf FM, Bergschmidt P, Pietschmann MF, Utzschneider S, Milz S, Jansson V, Müller PE, J Biomed Mater Res A 2010 95 735 740 20725984
127. Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury. McCarty RC, Xian CJ, Gronthos S, Zannettino AC, Foster BK, Open Orthop J 2010 4 204 210 10.2174/ 1874325001004010204 20721323
128. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S, Ghaderi A, Knee 2010 18 71 75 20591677
129. The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration. Wang CZ, Chen SM, Chen CH, Wang CK, Wang GJ, Chang JK, Ho ML, Biomaterials 2010 31 8674 8683 10.1016/j.biomaterials.2010.07. 096 20719378
130. Repair of full-thickness tendon injury using connective tissue progenitors efficiently derived from human embryonic stem cells and fetal tissues. Cohen S, Leshansky L, Zussman E, Burman M, Srouji S, Livne E, Abramov N, Itskovitz-Eldor J, Tissue Eng Part A 2010 16 3119 3137 10.1089/ten.tea.2009. 0716 20486794
131. Stem cell therapy in a caprine model of osteoarthritis. Murphy JM, Fink DJ, Hunziker EB, Barry FP, Arthritis Rheum 2003 48 3464 3474 10.1002/art.11365 14673997 (Pubitemid 37531912)
132. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK, Nat Med 1999 5 309 313 10.1038/6529 10086387 (Pubitemid 29124367)